NIH

Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Amgen
Prolia
Xgeva
denosumab
clinical trials
NIH
biosimilars
monoclonal antibodies
Flag link:
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Flag link:
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Flag link:
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi
Fierce Pharma
Pfizer
Astellas
Xtandi
prostate cancer
drug pricing
NIH
march-in rights
Flag link:
Synaptogenix reports disappointing data from Phase II Alzheimer’s trial
Synaptogenix reports disappointing data from Phase II Alzheimer’s trial
Clinical Trials Arena
Synaptogenix
clinical trials
NIH
Alzheimer's disease
Bryostatin-1
Flag link:
NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins
NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins
Drugs.com
phages
clinical trials
NIH
cystic fibrosis
Adaptive Phage Therapeutics
Flag link:
NIH launches the next stage of its ‘human genome project’ for the brain
NIH launches the next stage of its ‘human genome project’ for the brain
Stat
NIH
Human Genome Project
brain cells
Flag link:
FDA, NIH initiative aims to speed development of drugs for ALS, other brain diseases
FDA, NIH initiative aims to speed development of drugs for ALS, other brain diseases
BioPharma Dive
ALS
drug development
NIH
FDA
Flag link:
Oligomerix receives NIH grant for Phase Ia Alzheimer’s disease study
Oligomerix receives NIH grant for Phase Ia Alzheimer’s disease study
Clinical Trials Arena
Oligomerix
NIH
clinical trials
Alzheimer's disease
OLX-07010
Flag link:
NIH awards $577m to antiviral drug developers
NIH awards $577m to antiviral drug developers
Biopharma Reporter
NIH
NIAID
antivirals
drug development
pandemic
Flag link:
NIH in talks with Pfizer to study a longer course of COVID drug Paxlovid, Fauci says
NIH in talks with Pfizer to study a longer course of COVID drug Paxlovid, Fauci says
Fierce Pharma
Pfizer
Paxlovid
COVID-19
NIH
Flag link:
Global license program to receive Covid-19 support from the NIH
Global license program to receive Covid-19 support from the NIH
Endpoints
WHO
Joe Biden
NIH
COVID-19
Medicines Patent Pool
Flag link:
March-in campaign on Pfizer's prostate cancer med Xtandi gets congressional backing. Will it matter?
March-in campaign on Pfizer's prostate cancer med Xtandi gets congressional backing. Will it matter?
Fierce Pharma
Pfizer
Astellas
prostate cancer
Xtandi
NIH
Flag link:
Moderna offers NIH co-ownership of COVID vaccine patent amid dispute with government
Moderna offers NIH co-ownership of COVID vaccine patent amid dispute with government
CBS News
NIH
Moderna Therapeutics
patents
vaccines
COVID-19
Flag link:
Molecular Partners' Covid-19 therapy proves inactiv
Molecular Partners' Covid-19 therapy proves inactiv
EP Vantage
Molecular Partners
COVID-19
clinical trials
NIH
Flag link:
Moderna, escalating dispute with NIH, claims government had no role in key vaccine patent
Moderna, escalating dispute with NIH, claims government had no role in key vaccine patent
BioPharma Dive
Moderna Therapeutics
vaccines
NIH
patents
COVID-19
Flag link:
Moderna squares off with US government over COVID jab patent
Moderna squares off with US government over COVID jab patent
Pharmaforum
Moderna Therapeutics
NIH
patents
COVID-19
vaccines
Flag link:
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
FDA
Bespoke Gene Therapy Consortium
NIH
FDA
gene therapy
Flag link:
Why Shares of Cassava Sciences Rose 15% Today
Why Shares of Cassava Sciences Rose 15% Today
Motley Fool
Cassava Sciences
Alzheimer's disease
simufilam
NIH
Flag link:
NIH launches study into COVID-19 vaccine booster among people with autoimmune disease
NIH launches study into COVID-19 vaccine booster among people with autoimmune disease
Biopharma Reporter
NIH
autoimmune disease
clinical trials
COVID-19
vaccines
boosters
Flag link:

Pages